Concepedia

Na Zhou

NZ

Statistics

Publications

14

Citations

638

H-Index

13

Active since

2012

Affiliations

Guangzhou Medical University(Current)

Guangzhou Women and Children Medical Center

Guangdong Academy of Medical Sciences

Shanghai Jiao Tong University

The 309th Hospital of Chinese People's Liberation Army

Na Zhou is an author at Guangzhou Medical University specializing in medicine, cardiology, and gene expression.

ORCID

Publications per year

2012–2023

14

Publications

14

Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis

Rongjun Zou, Wanting Shi, Junxiong Qiu et al. · Cardiovascular Diabetology · 2022 · 125 citations · Full text

, , +17

SGLT2 inhibitor dapagliflozin reduces endothelial dysfunction and microvascular damage during cardiac ischemia/reperfusion injury through normalizing the XO-SERCA2-CaMKII-coffilin pathways

Li Ma, Rongjun Zou, Wanting Shi et al. · Theranostics · 2022 · 119 citations · Full text

, , +17

MicroRNA-138 inhibits proliferation, migration and invasion through targeting hTERT in cervical cancer

Na Zhou, Dan Fei, Shan Zong et al. · Oncology Letters · 2016 · 51 citations · Full text

, , +17

Deubiquitinase OTUD3 regulates metabolism homeostasis in response to nutritional stresses

Na Zhou, Hailong Qi, Junjun Liu et al. · Cell Metabolism · 2022 · 50 citations

, , +12

Hemoglobin A1c Levels and Aortic Arterial Stiffness: The Cardiometabolic Risk in Chinese (CRC) Study

Jun Liang, Na Zhou, Fei Teng et al. · PLoS ONE · 2012 · 49 citations · Full text

, , +16

1–5 of 14